The global healthcare sector is experiencing a paradigmatic transformation, catalyzed by pioneering breakthroughs in precision medicine and innovative therapeutic platforms. Leading this medical revolution is the remarkable development of Antibody Drug Conjugates (ADCs)—highly engineered pharmaceutical systems that seamlessly integrate the selective targeting power of monoclonal...